Giuseppina Brancaccio
YOU?
Author Swipe
View article: Association Between Sustained Virological Response and Adverse Liver-related Events in Patients With Decompensated Hepatitis C Virus Cirrhosis
Association Between Sustained Virological Response and Adverse Liver-related Events in Patients With Decompensated Hepatitis C Virus Cirrhosis Open
SVR was associated with a reduced risk of LREs in patients with decompensated HCV cirrhosis with a MELD score <15, whereas no clinical benefit was observed in those with higher MELD scores despite an SVR-associated MELD decrease.
View article: Waiting list mortality and 5-year transplant survival benefit of patients with MASLD: An Italian liver transplant registry study
Waiting list mortality and 5-year transplant survival benefit of patients with MASLD: An Italian liver transplant registry study Open
View article: A holistic evaluation of patients with chronic Hepatitis D virus (HDV) infection enrolled in the Italian PITER-B and delta cohort
A holistic evaluation of patients with chronic Hepatitis D virus (HDV) infection enrolled in the Italian PITER-B and delta cohort Open
View article: Reduction of the Risk of Hepatocellular Carcinoma over Time Using Direct-Acting Antivirals: A Propensity Score Analysis of a Real-Life Cohort (PITER HCV)
Reduction of the Risk of Hepatocellular Carcinoma over Time Using Direct-Acting Antivirals: A Propensity Score Analysis of a Real-Life Cohort (PITER HCV) Open
The treatment of hepatitis C virus (HCV) with direct-acting antivirals (DAA) leads to high sustained virological response (SVR) rates, but hepatocellular carcinoma (HCC) risk persists in people with advanced liver disease even after SVR. W…
View article: Determinants of worse liver‐related outcome according to <scp>HDV</scp> infection among <scp>HBsAg</scp> positive persons living with <scp>HIV</scp>: Data from the <scp>ICONA</scp> cohort
Determinants of worse liver‐related outcome according to <span>HDV</span> infection among <span>HBsAg</span> positive persons living with <span>HIV</span>: Data from the <span>ICONA</span> cohort Open
Objectives We aimed to study hepatitis D virus (HDV) prevalence and risk of progression to severe liver‐related events (SLRE) in HBsAg positive people living with HIV (PLWH) in Italy; role of HDV‐RNA copy levels, HCV coinfection and nadir …
View article: Predicting <i>de‐novo</i> portal vein thrombosis after HCV eradication: A long‐term competing risk analysis in the ongoing PITER cohort
Predicting <i>de‐novo</i> portal vein thrombosis after HCV eradication: A long‐term competing risk analysis in the ongoing PITER cohort Open
Background & Aims Sustained virological response (SVR) by direct‐acting antivirals (DAAs) may reverse the hypercoagulable state of HCV cirrhosis and the portal vein thrombosis (PVT) risk. We evaluated the incidence and predictive factors o…
View article: Uncover a microbiota signature of upper respiratory tract in patients with SARS-CoV-2 +
Uncover a microbiota signature of upper respiratory tract in patients with SARS-CoV-2 + Open
The outbreak of Coronavirus disease 2019 (COVID-19), caused by SARS-CoV-2, forced us to face a pandemic with unprecedented social, economic, and public health consequences. Several nations have launched campaigns to immunize millions of pe…
View article: Uncover a microbiota signature of upper respiratory tract in patients with SARS-CoV-2+
Uncover a microbiota signature of upper respiratory tract in patients with SARS-CoV-2+ Open
<p>This is the repository containing the code used to obtain the results shown in <a href="https://doi.org/10.1038/s41598-023-43040-x"><i><strong>Bellato M, Cappellato M, Longhin F, Del Vecchio C, Brancaccio G, Catt…
View article: Uncover a microbiota signature of upper respiratory tract in patients with SARS-CoV-2+
Uncover a microbiota signature of upper respiratory tract in patients with SARS-CoV-2+ Open
This is the repository containing the code used to obtain the results shown in Bellato M, Cappellato M, Longhin F, Del Vecchio C, Brancaccio G, Cattelan AM, Brun P, Salaris C, Castagliuolo I, Di Camillo B. "Uncover a microbiota signature o…
View article: Trends in chronic hepatitis B virus infection in Italy over a 10-year period: Clues from the nationwide PITER and MASTER cohorts toward elimination
Trends in chronic hepatitis B virus infection in Italy over a 10-year period: Clues from the nationwide PITER and MASTER cohorts toward elimination Open
View article: Profiling the risk of hepatocellular carcinoma after long-term HCV eradication in patients with liver cirrhosis in the PITER cohort
Profiling the risk of hepatocellular carcinoma after long-term HCV eradication in patients with liver cirrhosis in the PITER cohort Open
View article: The Survival Benefit of Liver Transplantation for Metabolic Associated Steatotic Liver Disease: An Italian Liver Transplant Registry Study
The Survival Benefit of Liver Transplantation for Metabolic Associated Steatotic Liver Disease: An Italian Liver Transplant Registry Study Open
View article: Impact of antigen test target failure and testing strategies on the transmission of SARS-CoV-2 variants
Impact of antigen test target failure and testing strategies on the transmission of SARS-CoV-2 variants Open
View article: Circulating Genotypes of Hepatitis C Virus in Italian Patients before and after the Application of Wider Access Criteria to HCV Treatment
Circulating Genotypes of Hepatitis C Virus in Italian Patients before and after the Application of Wider Access Criteria to HCV Treatment Open
Aims: The aims of this study were to report a description of the HCV genotype distribution in adult Italians and non-Italians subjects tested in the Microbiology and Virology Unit of the Padova University Hospital from January 2016 (after …
View article: Recent breakthroughs in the treatment of chronic hepatitis Delta
Recent breakthroughs in the treatment of chronic hepatitis Delta Open
Hepatitis Delta virus (HDV) is responsible for the most aggressive form of chronic hepatitis, which may evolve towards cirrhosis, hepatocellular carcinoma and death within few years. During the last 30 years the only available therapy was …
View article: Impact of antigen test target failure and testing strategies on the transmission of SARS-CoV-2 variants
Impact of antigen test target failure and testing strategies on the transmission of SARS-CoV-2 variants Open
Population testing remains central to COVID-19 control and surveillance, with countries increasingly using antigen tests rather than molecular tests. Here we describe a SARS-CoV-2 variant that escapes N antigen tests due to multiple disrup…
View article: Hepatitis delta coinfection in persons with HIV: misdiagnosis and disease burden in Italy
Hepatitis delta coinfection in persons with HIV: misdiagnosis and disease burden in Italy Open
Hepatitis Delta virus (HDV) causes severe liver disease. Due to similarities in transmission routes, persons living with HIV (PLWH) are at risk of HDV infection. This analysis investigates the prevalence and the long-term clinical outcome …
View article: Hepatitis delta coinfection in persons with HIV: misdiagnosis and disease burden in Italy
Hepatitis delta coinfection in persons with HIV: misdiagnosis and disease burden in Italy Open
Hepatitis Delta virus (HDV) causes severe liver disease. Due to similarities in transmission routes, persons living with HIV (PLWH) are at risk of HDV infection. This analysis investigates the prevalence and the long-term clinical outcome …
View article: A prospective study of direct‐acting antiviral effectiveness and relapse risk in HCV cryoglobulinemic vasculitis by the Italian PITER cohort
A prospective study of direct‐acting antiviral effectiveness and relapse risk in HCV cryoglobulinemic vasculitis by the Italian PITER cohort Open
Background and Aims Mixed cryoglobulinemia is the most common HCV extrahepatic manifestation. We aimed to prospectively evaluate the cryoglobulinemic vasculitis (CV) clinical profile after a sustained virologic response (SVR) over a medium…
View article: Liver function following hepatitis C virus eradication by direct acting antivirals in patients with liver cirrhosis: data from the PITER cohort
Liver function following hepatitis C virus eradication by direct acting antivirals in patients with liver cirrhosis: data from the PITER cohort Open
View article: Overview of Prognostic Systems for Hepatocellular Carcinoma and ITA.LI.CA External Validation of MESH and CNLC Classifications
Overview of Prognostic Systems for Hepatocellular Carcinoma and ITA.LI.CA External Validation of MESH and CNLC Classifications Open
Prognostic assessment in patients with HCC remains an extremely difficult clinical task due to the complexity of this cancer where tumour characteristics interact with degree of liver dysfunction, patient general health status, and a large…
View article: An Increase in the Levels of Middle Surface Antigen Characterizes Patients Developing HBV-Driven Liver Cancer Despite Prolonged Virological Suppression
An Increase in the Levels of Middle Surface Antigen Characterizes Patients Developing HBV-Driven Liver Cancer Despite Prolonged Virological Suppression Open
Hepatitis B virus (HBV) contains three surface glycoproteins—Large-HBs (L-HBs), Middle-HBs (M-HBs), and Small-HBs (S-HBs), known to contribute to HBV-driven pro-oncogenic properties. Here, we examined the kinetics of HBs-isoforms in virolo…
View article: Emergence of N antigen SARS-CoV-2 genetic variants escaping detection of antigenic tests
Emergence of N antigen SARS-CoV-2 genetic variants escaping detection of antigenic tests Open
SARS-CoV-2 genetic variants are emerging as a major threat to vaccination efforts worldwide as they may increase virus transmission rate and/or confer the ability to escape vaccine induced immunity with knock on effects on the level of her…
View article: Liver Transplantation for T2 Hepatocellular Carcinoma during the COVID-19 Pandemic: A Novel Model Balancing Individual Benefit against Healthcare Resources
Liver Transplantation for T2 Hepatocellular Carcinoma during the COVID-19 Pandemic: A Novel Model Balancing Individual Benefit against Healthcare Resources Open
The COVID-19 pandemic caused temporary drops in the supply of organs for transplantation, leading to renewed debate about whether T2 hepatocellular carcinoma (HCC) patients should receive priority during these times. The aim of this study …
View article: Cutaneous manifestations in a series of 417 patients with SARS-CoV-2 infection: epidemiological and clinical correlates of chilblain like lesions
Cutaneous manifestations in a series of 417 patients with SARS-CoV-2 infection: epidemiological and clinical correlates of chilblain like lesions Open
A variety of dermatological lesions have been described in COVID-19, although the prevalence and pathogenic relationship remain unclear particularly for chilblain-like lesions. Dermatological examination was performed in a prospective coho…
View article: Liver Transplantation during the COVID-19 pandemic: A quantitative model balancing individual patient benefit against population healthcare needs
Liver Transplantation during the COVID-19 pandemic: A quantitative model balancing individual patient benefit against population healthcare needs Open
View article: Liver Function Following Hepatitis C Virus Eradication by Direct Acting Antivirals in Patients With Liver Cirrhosis: Data from The PITER Cohort
Liver Function Following Hepatitis C Virus Eradication by Direct Acting Antivirals in Patients With Liver Cirrhosis: Data from The PITER Cohort Open
Background: The development of direct-acting antivirals (DAA) for HCV has revolutionized the treatment of HCV, including its treatment in patients with HIV coinfection. The aim of this study was to compare the changes in liver function bet…
View article: Prophylaxis of Hepatitis B Virus (HBV) Re-Infection in Liver Transplantation: Is the Reappearance of Hepatitis B Surface Antigen (HBsAg) Significant?
Prophylaxis of Hepatitis B Virus (HBV) Re-Infection in Liver Transplantation: Is the Reappearance of Hepatitis B Surface Antigen (HBsAg) Significant? Open
The recurrence of hepatitis B virus (HBV) infection after orthotopic liver transplantation (OLT) was in the past a primary cause of organ loss or mortality. Currently, post-OLT prophylaxis with anti-HBs immunoglobulins plus a nucleos(t)ide…
View article: Letter: clinical outcomes of patients with hepatitis D infection in the liver transplant setting—authors' reply
Letter: clinical outcomes of patients with hepatitis D infection in the liver transplant setting—authors' reply Open
LINKED CONTENT This article is linked to Brancaccio et al and Brancaccio and Ferrarese et al papers. To view this articles, visit https://doi.org/10.1111/apt.15188 and https://doi.org/10.1111/apt.15619 .
View article: Sunscreen ingredients in plasma: a threat for drug–drug interactions and toxicity among patients living with HIV?
Sunscreen ingredients in plasma: a threat for drug–drug interactions and toxicity among patients living with HIV? Open